<DOC>
	<DOC>NCT01321268</DOC>
	<brief_summary>To investigate the safety and efficacy of a dietary supplement on cellulite alleviation, fat deposits and quality of life.</brief_summary>
	<brief_title>Safety and Efficacy of a Dietary Supplement in Females With Cellulite</brief_title>
	<detailed_description>The study will be conducted as a single centre, randomized, double-blind, controlled, parallel group study with healthy female volunteers, aged 18-45 years of age, with skin phototypes I to VI and a clinical diagnosis of cellulite on buttocks (at least score 6 at Cellulite Severity Scale (CSS)). The study will take 24 weeks (6 months) per subject. There will be one previsit during the screening phase and 8 visits per subject during the treatment phase. Safety and efficacy variables will be performed monthly.</detailed_description>
	<mesh_term>Resveratrol</mesh_term>
	<mesh_term>Lycopene</mesh_term>
	<mesh_term>Carotenoids</mesh_term>
	<mesh_term>Beta Carotene</mesh_term>
	<criteria>Healthy female volunteers Age between 18 and 45 years at Day 01 of the study Body mass index (BMI) from 18.5 24.9 All Fitzpatrick skin types CSS score of at least 6 Normal eating habits (no vegetarians or vegans) Written informed consent Menopause and premenopause Smoking Pregnant women or women intending to become pregnant during study Lactation period Any kind of dermatological conditions Vegetarians or vegans Any kind of hepatitis, including any alteration in transaminases Use of illicit drugs Other surgical or internal diseases e.g. a metabolic or endocrine disease that may affect the outcome of the study (e.g. diabetes, liver diseases, kidney disorders) or having a history of medical or surgical events that may significantly affect the study outcome including any cardiovascular disease, skin disease, hypertension (&gt;160/95 mm Hg at repeated measurements) Existence of scars and/or pigmentation in measurement areas (thighs and buttocks), which can influence study measurements Participation in any other clinical trial including blood sampling and/or administration or substances up to 30 days before Day 01 of this study Any prior aesthetic surgery (Liposuction, SubcisionÂ®), 3 months before the study, that may interfere with results Any other prior anticellulite treatment or body measures treatment, 30 days prior to the study Participation in any other noninvasive clinical trial up to 30 days before Day 01 of this study, including blood sampling Recent blood or plasmapherese donation (less than 1 month prior to Day 01 of the study) Under medical treatment for a skin disease in the past and/or present with a therapy, which may influence the results of the study (systemic steroids or antibiotics, local steroids or topical immunomodulators during the last 3 months Use of sun beds or selftanning products or sun exposure for one month before and during study Not willing to accept informationtransfer concerning participation in the study, or information regarding his/her health, like laboratory results, findings at anamnesis or physical examination and eventual adverse events to and from his general practitioner Subjects intending to initiate any intensive sports Every other condition that the investigator might consider to involve a risk for the study subject.</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>45 Years</maximum_age>
	<verification_date>February 2012</verification_date>
	<keyword>orange peel skin</keyword>
	<keyword>cellulite</keyword>
</DOC>